FI3849970T3 - Kiteinen (r)-5-karbamoyylipyridin-3-yyli-2-metyyli-4-(3-(trifluorimetoksi)bentsyyli)piperatsiini-1-karboksylaatti, sen koostumuksia ja käyttömenetelmiä - Google Patents
Kiteinen (r)-5-karbamoyylipyridin-3-yyli-2-metyyli-4-(3-(trifluorimetoksi)bentsyyli)piperatsiini-1-karboksylaatti, sen koostumuksia ja käyttömenetelmiä Download PDFInfo
- Publication number
- FI3849970T3 FI3849970T3 FIEP19778721.1T FI19778721T FI3849970T3 FI 3849970 T3 FI3849970 T3 FI 3849970T3 FI 19778721 T FI19778721 T FI 19778721T FI 3849970 T3 FI3849970 T3 FI 3849970T3
- Authority
- FI
- Finland
- Prior art keywords
- crystal form
- degrees
- powder
- ray diffraction
- diffraction pattern
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/94—Oxygen atom, e.g. piperidine N-oxide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862731014P | 2018-09-13 | 2018-09-13 | |
| PCT/US2019/050771 WO2020056105A1 (en) | 2018-09-13 | 2019-09-12 | Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl) piperazine-1-carboxylate, compositions and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3849970T3 true FI3849970T3 (fi) | 2024-09-20 |
Family
ID=68069873
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP19778721.1T FI3849970T3 (fi) | 2018-09-13 | 2019-09-12 | Kiteinen (r)-5-karbamoyylipyridin-3-yyli-2-metyyli-4-(3-(trifluorimetoksi)bentsyyli)piperatsiini-1-karboksylaatti, sen koostumuksia ja käyttömenetelmiä |
| FIEP24185102.1T FI4434583T3 (fi) | 2018-09-13 | 2019-09-12 | Kiteinen(R)-5-karbamoyylipyridin-3-yyli-2-metyyli-4-(3-(trifluorimetoksi)bentsyyli) piperatsiini-1-karboksylaatti, sen koostumukset ja käytöt |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP24185102.1T FI4434583T3 (fi) | 2018-09-13 | 2019-09-12 | Kiteinen(R)-5-karbamoyylipyridin-3-yyli-2-metyyli-4-(3-(trifluorimetoksi)bentsyyli) piperatsiini-1-karboksylaatti, sen koostumukset ja käytöt |
Country Status (28)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2993173T3 (en) | 2018-09-13 | 2024-12-23 | Celgene Corp | Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl) piperazine-1-carboxylate, compositions and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007010076A (es) * | 2005-02-17 | 2007-10-16 | Astellas Pharma Inc | Derivado de heterociclico-1-carboxilato que contiene nitrogeno no aromatico de piridilo. |
| EP3099332A4 (en) * | 2014-01-29 | 2017-06-21 | Madrigal Pharmaceuticals, Inc. | Targeted therapeutics |
| PT3595665T (pt) * | 2017-03-13 | 2024-11-21 | Lundbeck La Jolla Research Center Inc | Inibidores duplos de magl e faah |
| ES2993173T3 (en) | 2018-09-13 | 2024-12-23 | Celgene Corp | Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl) piperazine-1-carboxylate, compositions and methods of use thereof |
-
2019
- 2019-09-12 ES ES19778721T patent/ES2993173T3/es active Active
- 2019-09-12 RS RS20260687A patent/RS68181B1/sr unknown
- 2019-09-12 FI FIEP19778721.1T patent/FI3849970T3/fi active
- 2019-09-12 IL IL281276A patent/IL281276B2/en unknown
- 2019-09-12 EP EP19778721.1A patent/EP3849970B1/en active Active
- 2019-09-12 MY MYPI2021001295A patent/MY208901A/en unknown
- 2019-09-12 FI FIEP24185102.1T patent/FI4434583T3/fi active
- 2019-09-12 LT LTEPPCT/US2019/050771T patent/LT3849970T/lt unknown
- 2019-09-12 CN CN202410683425.0A patent/CN118561814A/zh active Pending
- 2019-09-12 CA CA3112200A patent/CA3112200A1/en active Pending
- 2019-09-12 WO PCT/US2019/050771 patent/WO2020056105A1/en not_active Ceased
- 2019-09-12 EP EP24185102.1A patent/EP4434583B1/en active Active
- 2019-09-12 MX MX2021002923A patent/MX2021002923A/es unknown
- 2019-09-12 PT PT241851021T patent/PT4434583T/pt unknown
- 2019-09-12 KR KR1020217010747A patent/KR102844245B1/ko active Active
- 2019-09-12 MA MA71839A patent/MA71839B1/fr unknown
- 2019-09-12 AU AU2019337623A patent/AU2019337623B2/en active Active
- 2019-09-12 SM SM20260252T patent/SMT202600252T1/it unknown
- 2019-09-12 ES ES24185102T patent/ES3072981T3/es active Active
- 2019-09-12 BR BR112021004340-3A patent/BR112021004340A2/pt unknown
- 2019-09-12 SI SI201930824T patent/SI3849970T1/sl unknown
- 2019-09-12 JP JP2021514123A patent/JP7405840B2/ja active Active
- 2019-09-12 CN CN201980060119.9A patent/CN113227069B/zh active Active
- 2019-09-12 HR HRP20260757TT patent/HRP20260757T1/hr unknown
- 2019-09-12 DK DK24185102.1T patent/DK4434583T5/da active
- 2019-09-12 PT PT197787211T patent/PT3849970T/pt unknown
- 2019-09-12 US US16/569,578 patent/US11053199B2/en active Active
- 2019-09-12 SM SM20240369T patent/SMT202400369T1/it unknown
- 2019-09-12 HR HRP20241294TT patent/HRP20241294T1/hr unknown
- 2019-09-12 SG SG11202102143RA patent/SG11202102143RA/en unknown
- 2019-09-12 EA EA202190511A patent/EA202190511A1/ru unknown
- 2019-09-12 EP EP26160625.5A patent/EP4768081A2/en active Pending
- 2019-09-12 HU HUE19778721A patent/HUE068147T2/hu unknown
- 2019-09-12 PL PL19778721.1T patent/PL3849970T3/pl unknown
- 2019-09-12 RS RS20241039A patent/RS65967B1/sr unknown
- 2019-09-12 MY MYPI2024007477A patent/MY210363A/en unknown
- 2019-09-12 DK DK19778721.1T patent/DK3849970T3/da active
- 2019-09-12 PL PL24185102.1T patent/PL4434583T3/pl unknown
- 2019-09-12 MA MA53607A patent/MA53607B1/fr unknown
- 2019-09-12 LT LTEP24185102.1T patent/LT4434583T/lt unknown
- 2019-09-12 CN CN202410683444.3A patent/CN118530218A/zh active Pending
-
2021
- 2021-03-10 CL CL2021000596A patent/CL2021000596A1/es unknown
- 2021-03-12 CO CONC2021/0003295A patent/CO2021003295A2/es unknown
- 2021-06-03 US US17/338,182 patent/US11680046B2/en active Active
-
2023
- 2023-05-05 US US18/143,765 patent/US12410133B2/en active Active
-
2025
- 2025-08-06 US US19/292,473 patent/US20260062384A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530565A5 (cg-RX-API-DMAC7.html) | ||
| JP2009537498A5 (cg-RX-API-DMAC7.html) | ||
| JP4619945B2 (ja) | 置換されたホモピペリジン、ピペリジンまたはピロリジン誘導体 | |
| DE2247330A1 (de) | Herbicide verbindung und verfahren zur herstellung derselben | |
| RU2014110399A (ru) | Кристаллические формы вгс протеазного ингибитора | |
| JP2018531280A5 (cg-RX-API-DMAC7.html) | ||
| EA200601266A1 (ru) | Соединения триазола и их применение в качестве антагонистов метаботропного рецептора глутамата | |
| CA2600203A1 (en) | New salt and polymorphs of a dpp-iv inhibitor | |
| TW202200594A (zh) | 一種glp-1受體激動劑的晶型a及其製備方法 | |
| JP2018524342A5 (cg-RX-API-DMAC7.html) | ||
| KR20090005369A (ko) | 중추 신경계 질환의 치료를 위한 (2s)-(4e)-n-메틸-5-(3-이소프로폭시피리딘)일]-4-펜텐-2-아민의 다형체 제형 | |
| JP2005520819A5 (cg-RX-API-DMAC7.html) | ||
| RU2019110048A (ru) | Твердые формы валбеназина | |
| RU2017134709A (ru) | П-толуолсульфонат для ингибитора мек-киназы и его кристаллическая форма, и способ его получения | |
| JP2024530164A5 (cg-RX-API-DMAC7.html) | ||
| JP2018503649A5 (cg-RX-API-DMAC7.html) | ||
| WO2014164648A4 (en) | Solid state forms of a quinazoline derivative and its use as a braf inhibitor | |
| RU2013120549A (ru) | Новые кристаллические формы натриевой соли(4-{4-[5-(6-трифторметил-пиридин-3-иламино) пиридин-2-ил] фенил} циклогексил) уксусной кислоты | |
| RU2008137725A (ru) | Новая соль | |
| HRP20241294T1 (hr) | Kristalni (r)-5-karbamoilpiridin-3-il-2-metil-4-(3-(trifluorometoksi)benzil) piperazin-1-karboksilat, pripravci i postupci njegove upotrebe | |
| WO2010045582A3 (en) | Compositions and methods for treating or preventing hypoxic or ischemic injury | |
| CA2553345A1 (en) | Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 | |
| Kouznetsov et al. | Transformation of schiff bases derived from alpha‐naphthaldehyde. Synthesis, spectral data and biological activity of new‐3‐aryl‐2‐(α‐naphtyl)‐4‐thiazolidinones and N‐aryl‐N‐[1‐(α‐naphthyl) but‐3‐enyl] amines | |
| JPH09328477A (ja) | 除草性イソオキサゾリン誘導体 | |
| Panda et al. | Microwave Induced Synthesis of 1, 2, 4-triazole derivatives and Study of their Anthelmintic and Anti-microbial Activities |